PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. SYNA
2. ON
3. SPY
4. MU
5. AAPL
6. VEON
7. SPCX
8. ABBV
9. DRI
10. ACAD

Go back to PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
(NASDAQ: PRTC) Delayed: 17.42 --0 (-0%)
Previous Close $17.42    52 Week High $ 
Open $17.42    52 Week Low $ 
Day High $17.42    P/E N/A 
Day Low $17.42    EPS $ 
Volume 500       

(NASDAQ: PRTC) Delayed: 17.42 --0 (-0%)
Previous Close $17.42    52 Week High $ 
Open $17.42    52 Week Low $ 
Day High $17.42    P/E N/A 
Day Low $17.42    EPS $ 
Volume 500